1 capsule contains:
magnesium ions 150 mg
in a form of heavy magnesium oxide
(Magnesii oxidum ponderosum) 250 mg
Pyridoxine hydrochloride
(Pyridoxini hydrochloridum, vitamin B6) 7.29 mg
all-rac-α-tocopheryl acetate
(int-rac-α-Tocopherylis acetas, vitamin E) 200 mg
Excipient: purified soybean oil 114.71 mg
Prevention and treatment of vitamin E, B6 and magnesium deficiencies.
MBE is a mineral and vitamin drug containing magnesium ions, vitamin B6 and vitamin E, which are indicated in the prevention and treatment of deficiencies in a period of increased demand for these vitamins and magnesium, in increased physical effort, elimination diet, in polluted environment and in smokers.
The drug is also indicated as an adjuvant in diseases resulting from from oxidative stress and in elimination of stress-induced conditions (due to anti-oxidative properties).
Hypersensitivity to any of the active substances or excipients.
Hypersensitivity to peanuts or soya.
Hypermagnesemia.
Acute renal failure.
Atrioventricular block.
Myasthenia gravis.
Severe arterial hypotension.
Levodopa therapy (L-DOPA) without peripheral decarboxylase inhibitors.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
This is a drug. For safety, use it according to the package insert and only when necessary. If in doubt, consult your doctor or pharmacist.
phone: (+48 22) 742 00 22
informacjaoleku@hasco-lek.pl
1 capsule contains:
magnesium ions 150 mg
in a form of heavy magnesium oxide
(Magnesii oxidum ponderosum) 250 mg
Pyridoxine hydrochloride
(Pyridoxini hydrochloridum, vitamin B6) 7.29 mg
all-rac-α-tocopheryl acetate
(int-rac-α-Tocopherylis acetas, vitamin E) 200 mg
Excipient: purified soybean oil 114.71 mg
Prevention and treatment of vitamin E, B6 and magnesium deficiencies.
MBE is a mineral and vitamin drug containing magnesium ions, vitamin B6 and vitamin E, which are indicated in the prevention and treatment of deficiencies in a period of increased demand for these vitamins and magnesium, in increased physical effort, elimination diet, in polluted environment and in smokers.
The drug is also indicated as an adjuvant in diseases resulting from from oxidative stress and in elimination of stress-induced conditions (due to anti-oxidative properties).
Hypersensitivity to any of the active substances or excipients.
Hypersensitivity to peanuts or soya.
Hypermagnesemia.
Acute renal failure.
Atrioventricular block.
Myasthenia gravis.
Severe arterial hypotension.
Levodopa therapy (L-DOPA) without peripheral decarboxylase inhibitors.
Przedsiębiorstwo Produkcji
Farmaceutycznej
Hasco-Lek S.A.
st. Żmigrodzka 242e
51-131 Wroclaw
phone: (+48) 71 352 95 22
fax: (+48) 71 352 76 36
hasco@hasco-lek.pl
